Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;74(2):297-300.
doi: 10.1002/ana.23899.

Inhibiting glycogen synthesis prevents Lafora disease in a mouse model

Bartholomew A Pederson  1 , Julie Turnbull, Jonathan R Epp, Staci A Weaver, Xiaochu Zhao, Nela Pencea, Peter J Roach, Paul W Frankland, Cameron A Ackerley, Berge A Minassian
Affiliations

Inhibiting glycogen synthesis prevents Lafora disease in a mouse model

Bartholomew A Pederson et al. Ann Neurol. 2013 Aug.

Abstract

Lafora disease (LD) is a fatal progressive myoclonus epilepsy characterized neuropathologically by aggregates of abnormally structured glycogen and proteins (Lafora bodies [LBs]), and neurodegeneration. Whether LBs could be prevented by inhibiting glycogen synthesis and whether they are pathogenic remain uncertain. We genetically eliminated brain glycogen synthesis in LD mice. This resulted in long-term prevention of LB formation, neurodegeneration, and seizure susceptibility. This study establishes that glycogen synthesis is requisite for LB formation and that LBs are pathogenic. It opens a therapeutic window for potential treatments in LD with known and future small molecule inhibitors of glycogen synthesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
LKO mice lacking GS (DKO mice) have no LB and no gliosis. (A–C) LB in the cerebellum (A), hippocampus (B), and skeletal muscle (C) of LKO mice. (D–F) Corresponding brain regions and muscle in DKO mice. (G–I) GFAP staining in the hippocampus of LKO (G), DKO (H), and WT (I) mice. Note the increase in astrocytes (gliosis) in the LKO mice; DKO mice are similar to WT.
Figure 2
Figure 2
DKO mice do not exhibit the neurodegeneration seen in LKO mice. (A, B) Representative low and high power electron micrographs of a cerebellar Purkinje cell from a WT mouse. Note the smooth linear cell contour and normal synaptic contacts with the cell membrane (arrow). (C, D) Corresponding images from a DKO mouse. Purkinje cells exhibit healthy cytoplasms, smooth linear cell membranes, and normal synaptic contacts similar to WT. (E, F) Purkinje cells from an LKO mouse. Note the darkened amorphous cytoplasms, wrinkled plasma membranes, and disturbed synaptic contacts; asterisk in E indicates a LB. (G) Part of a Purkinje cell from an LKO mouse with multiple surrounding LB (asterisks).
Figure 3
Figure 3
LKO mice exhibit a much more severe epileptic response to kainic acid than WT. DKO mice are similar to WT. n = 3–8 mice per genotype, 20–26 months of age. Data is shown as means ± SEM and significance calculated using an unpaired student’s t-test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lafora GR, Glueck B. Beitrag zur Histopathologie der myoklonischen Epilepsie. Zeitschrift Gesamte Neurologische Psychiatrie. 1911;6:1–14.
    1. Sakai M, Austin J, Witmer F, Trueb L. Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology. 1970 Feb;20(2):160–76. - PubMed
    1. Tiberia E, Turnbull J, Wang T, et al. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease. J Biol Chem. 2012 Jul 20;287(30):25650–9. - PMC - PubMed
    1. Gentry MS, Worby CA, Dixon JE. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8501–6. - PMC - PubMed
    1. Tagliabracci VS, Girard JM, Segvich D, et al. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol Chem. 2008 Dec 5;283(49):33816–25. - PMC - PubMed

Publication types